JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.56B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.56B |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.17B |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$777M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.82B |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.38B |
| 3 |
Apple
AAPL
|
+$977M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$915M |
| 5 |
Walt Disney
DIS
|
+$778M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.46% |
| 2 | Technology | 11.62% |
| 3 | Healthcare | 10.99% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AQUA
3276
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $1.61M | ﹤0.01% |
167,991
-5,224,619
| -97% | -$60.2M |
|
3277
VEON
VEON
$3.62B
| $1.61M | ﹤0.01% |
27,556
-94,816
| -77% | -$6.4M |
|
3278
Zurn Elkay Water Solutions
ZWS
$8.38B
| $1.61M | ﹤0.01% |
145,251
-31,977
| -18% | -$415K |
|
3279
Rayonier Advanced Materials
RYAM
$604M
| $1.6M | ﹤0.01% |
150,164
-115,666
| -44% | -$1.57M |
|
|
BMCH
3280
DELISTED
BMC Stock Holdings, Inc
BMCH
| $1.6M | ﹤0.01% |
103,296
+87,607
| +558% | +$1.46M |
|
3281
Interparfums
IPAR
$3.99B
| $1.6M | ﹤0.01% |
24,369
+962
| +4% | +$57.8K |
|
3282
Neogen
NEOG
$2.63B
| $1.6M | ﹤0.01% |
56,106
+25,330
| +82% | +$792K |
|
|
KG
3283
Kestrel Group
KG
$69.4M
| $1.59M | ﹤0.01% |
48,251
+45,358
| +1,568% | +$2.44M |
|
|
BDSI
3284
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.59M | ﹤0.01% |
429,913
+162,039
| +60% | +$569K |
|
3285
PUT
Incyte
INCY
$24.2B
| $1.59M | ﹤0.01% |
25,000
-250,000
| -91% | -$16.2M |
|
3286
West Bancorporation
WTBA
$478M
| $1.59M | ﹤0.01% |
83,286
+466
| +0.6% | +$9.85K |
|
3287
CALL
Hain Celestial
HAIN
$45M
| $1.59M | ﹤0.01% |
100,000
+88,900
| +801% | +$1.98M |
|
|
BHBK
3288
DELISTED
Blue Hills Bancorp, Inc.
BHBK
| $1.59M | ﹤0.01% |
74,357
+64,189
| +631% | +$1.48M |
|
3289
CALL
AvalonBay Communities
AVB
$26.5B
| $1.58M | ﹤0.01% |
9,100
-900
| -9% | -$163K |
|
3290
FNB Corp
FNB
$6.73B
| $1.58M | ﹤0.01% |
160,994
+14,616
| +10% | +$170K |
|
3291
LivePerson
LPSN
$21.8M
| $1.58M | ﹤0.01% |
5,600
+3,074
| +122% | +$948K |
|
3292
PUT
NRG Energy
NRG
$28.3B
| $1.58M | ﹤0.01% |
40,000
| – | – |
|
|
GMS
3293
DELISTED
GMS Inc
GMS
| $1.58M | ﹤0.01% |
106,487
-144,813
| -58% | -$2.54M |
|
|
GMLP
3294
DELISTED
Golar LNG Partners LP
GMLP
| $1.58M | ﹤0.01% |
146,554
-757,843
| -84% | -$9.96M |
|
3295
B2Gold
BTG
$5B
| $1.58M | ﹤0.01% |
542,013
+225,442
| +71% | +$587K |
|
3296
Consolidated Water Co
CWCO
$467M
| $1.58M | ﹤0.01% |
135,684
+16,373
| +14% | +$205K |
|
3297
PUT
Parker-Hannifin
PH
$123B
| $1.58M | ﹤0.01% |
+10,600
| New | +$1.72M |
|
|
ACHN
3298
DELISTED
Achillion Pharmaceuticals
ACHN
| $1.58M | ﹤0.01% |
992,714
-46,724
| -4% | -$132K |
|
3299
CALL
CRISPR Therapeutics
CRSP
$4.73B
| $1.57M | ﹤0.01% |
55,000
-2,000
| -4% | -$69.5K |
|
|
3300
PUT
CRISPR Therapeutics
CRSP
$4.73B
| $1.57M | ﹤0.01% |
55,000
-32,000
| -37% | -$1.11M |
|
Similar funds
JP Morgan Chase's Q4 2018 Portfolio in Review
As of Q4 2018, JP Morgan Chase held 6,191 positions worth $432B, down 17% from $522B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase withdrew a net $17.1B in Q4 2018, closing 424 positions and reducing 2,219 holdings. Its most notable exit was Energen, an estimated $648M position sold in full.
By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.
Against the trend, JP Morgan Chase opened a new position in Linde worth $751M.
- JP Morgan Chase's largest Q4 2018 buy was Linde: 4,813,392 shares worth $751M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q4 2018, an estimated $1.56B increase.
- JP Morgan Chase's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.82B.
- JP Morgan Chase fully exited Energen in Q4 2018, selling an estimated $648M.
- JP Morgan Chase's ten largest holdings make up 16% of its $432B portfolio in Q4 2018.
- JP Morgan Chase opened 487 new positions and closed 424 in Q4 2018.
- JP Morgan Chase's portfolio value fell 17% quarter-over-quarter to $432B.
Based on JP Morgan Chase's 13F filing for Q4 2018, filed 11 Feb 2019.